CFTR modulator | European Cystic Fibrosis Society (ECFS)

How people with CF access CFTR modulators in countries where coverage is not provided by health systems

Use of Elexacaftor/Tezacaftor/Ivacaftor in Pregnant Mothers without CF to Treat Meconium Ileus in Fetuses with Cystic Fibrosis

Understanding rates of and factors associated with elexacaftor/tezacaftor/ivacaftor (ETI) prescription

How have prescriptions for inhaled antibiotics changed in recent years in the U.S.

A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans

Evaluating the Effectiveness of a Novel CF Medication for People Without Common Cystic Fibrosis-causing Genetic Mutations

A Review of Cystic Fibrosis Sinus and Nasal Disease response to CFTR Modulator Therapy

Examining the potential for drug interactions with Trikafta®/Kaftrio® in people with cystic fibrosis

Current Prices versus Minimum Costs of Production for CFTR Modulators

The effect of CFTR modulation with elexacaftor-tezacaftor-ivacaftor on the anxiety sweat rate in people with cystic fibrosis

1
2
3
next
last